Pfizer's (NYSE: PFE) burgeoning tiff with activist investor group Starboard Value looks like it's escalating. Since the ...

Newcomers will be plugging into the stock while its forward-looking dividend yield stands at 5.8%. There's a decent chance ...

Pfizer Inc.’s stock dipped 2.5% Thursday as the company’s battle with activist shareholder Starboard Value heated up, after two former executives for the pharma giant said they would not ...

Pfizer CEO Albert Bourla is in a tough spot as activist investor Starboard Value continues to call for a change in the ...

At an investor summit in New York on Tuesday, activist investor Starboard called out Pfizer's PFE board of directors to take ...

Activist investor Starboard met with Pfizer last week. Here's what went down, according to the hedge fund's cofounder and CEO ...

GM's recent success puts pressure on Tesla as it fights to maintain its EV dominance ahead of today's earnings report.

Me CEO Anne Wojcicki continues to maintain a strong outlook despite recent high-profile stumbles. “We are a long-term company ...

Despite that cash windfall, Pfizer has "dramatically underperformed its peers and the market since 2019," according to ...

Starboard Value LP Chief Executive Officer Jeffrey Smith said there has been at least $20 billion in value destruction at drugmaker Pfizer Inc., which he admonished for failing to deliver on a ...

Starboard Value criticizes Pfizer's leadership for underperformance, citing a 50% stock decline and missed growth targets ...

Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job.